Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparability of a provisioned device versus bring your own device for completion of patient-reported outcome measures by participants with chronic obstructive pulmonary disease: quantitative study findings.
Hudgens S, Newton L, Eremenco S, Crescioni M, Symonds T, Griffiths PCG, Reasner DS, Byrom B, O'Donohoe P, Vallow S; Patient-Reported Outcome (PRO) Consortium and Electronic Clinical Outcome Assessment (eCOA) Consortium. Hudgens S, et al. J Patient Rep Outcomes. 2022 Nov 26;6(1):119. doi: 10.1186/s41687-022-00521-3. J Patient Rep Outcomes. 2022. PMID: 36435889 Free PMC article.
Atherosclerotic risk factor reduction in peripheral arterial diseasea: results of a national physician survey.
McDermott MM, Hahn EA, Greenland P, Cella D, Ockene JK, Brogan D, Pearce WH, Hirsch AT, Hanley K, Odom L, Khan S, Criqui MH, Lipsky MS, Hudgens S. McDermott MM, et al. Among authors: hudgens s. J Gen Intern Med. 2002 Dec;17(12):895-904. doi: 10.1046/j.1525-1497.2002.20307.x. J Gen Intern Med. 2002. PMID: 12472925 Free PMC article. Clinical Trial.
Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trial.
Saad F, Cella D, Basch E, Hadaschik BA, Mainwaring PN, Oudard S, Graff JN, McQuarrie K, Li S, Hudgens S, Lawson J, Lopez-Gitlitz A, Yu MK, Smith MR, Small EJ. Saad F, et al. Among authors: hudgens s. Lancet Oncol. 2018 Oct;19(10):1404-1416. doi: 10.1016/S1470-2045(18)30456-X. Epub 2018 Sep 10. Lancet Oncol. 2018. PMID: 30213449 Clinical Trial.
Relationship Between Symptoms and Health-related Quality-of-life Benefits in Patients With Carcinoid Syndrome: Post Hoc Analyses From TELESTAR.
Cella D, Beaumont JL, Hudgens S, Marteau F, Feuilly M, Houchard A, Lapuerta P, Ramage J, Pavel M, Hörsch D, Kulke MH. Cella D, et al. Among authors: hudgens s. Clin Ther. 2018 Dec;40(12):2006-2020.e2. doi: 10.1016/j.clinthera.2018.10.008. Epub 2018 Nov 24. Clin Ther. 2018. PMID: 30477789 Free article. Clinical Trial.
Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial.
Cortes J, Hudgens S, Twelves C, Perez EA, Awada A, Yelle L, McCutcheon S, Kaufman PA, Forsythe A, Velikova G. Cortes J, et al. Among authors: hudgens s. Breast Cancer Res Treat. 2015 Dec;154(3):509-20. doi: 10.1007/s10549-015-3633-7. Epub 2015 Nov 14. Breast Cancer Res Treat. 2015. PMID: 26567010 Free PMC article. Clinical Trial.
Adalimumab alleviates skin pain in patients with moderate-to-severe hidradenitis suppurativa: Secondary efficacy results from the PIONEER I and PIONEER II randomized controlled trials.
Kimball AB, Sundaram M, Shields AL, Hudgens S, Okun M, Foley C, Ganguli A. Kimball AB, et al. Among authors: hudgens s. J Am Acad Dermatol. 2018 Dec;79(6):1141-1143. doi: 10.1016/j.jaad.2018.05.015. Epub 2018 May 19. J Am Acad Dermatol. 2018. PMID: 29787843 No abstract available.
68 results